Free
About
North American Consortium for the Study of End-Stage Liver Disease (NACSELD) consists of several tertiary care centers which prospectively studies inpatient and outpatient outcomes in hospitalized patients with cirrhosis. Calculators based on published research predicting 30- day mortality and probability of fungal infection development are included in the App. This is meant for research purposes only.
Show more
What's New in NACSELD
1.1
January 21, 2022
Updated to support the latest version of iOS.
